Home
 /
Papers
 /
Biochemistry
 /
High-throughput diversification of protein-ligand surfaces to discover chemical inducers of proximity
Preprint
Open access
V1
Top 1% · Validated by QED

High-throughput diversification of protein-ligand surfaces to discover chemical inducers of proximity

James B. Shaum, Miquel Muñoz i Ordoño, Erica A. Steen +31 more
September 2025
 ·
bioRxiv
 ·
DOI 
10.1101/2024.09.30.615685
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Biochemistry this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

Replacing serendipity with a systematic SuFEx chemistry platform, this work makes molecular glue discovery prospective and scalable, unlocks FBXO3 as a new E3 ligase, and reveals a cooperative mechanism that redefines degrader selectivity.

QED claims analysis

Summary

High-throughput chemical diversification using SuFEx chemistry enables the prospective discovery of molecular glue degraders that cooperatively recruit E3 ligases to pre-selected targets through extensive protein-protein contacts, as demonstrated by dHTC1, which degrades ENL through CRBN with 220-fold cooperativity despite minimal independent ligase affinity, and dHTC3, which accesses the previously unexploited SCFFBXO3 pathway for bromodomain-selective BRD4 degradation.

See full analysis
Main Claim 1 –

SuFEx high-throughput diversification converts ligands into CIPs

Supporting evidence

  • dHTC1 drives sustained ENL degradation across AML cell lines
  • dHTC1 requires ENL binding and proteasome/CRL-dependent degradation
  • dHTC1 selectively degrades ENL and suppresses ENL target genes
Main Claim 2 –

CRISPR screen shows dHTC1 recruits CRL4CRBN to ENL

Supporting evidence

  • CRBN knockout blocks, and overexpression enhances, dHTC1 activity
  • SPR/APMS detect dHTC1-induced ENL–CRBN/SEC ternary interactions
Main Claim 3 –

dHTC1 cooperatively engages CRBN only after ENL binding

Supporting evidence

  • dHTC1 weakly binds CRBN and cannot displace CRBN PROTACs
  • (S)-dHTC1 alone degrades ENL despite equal ENL binding
  • Sulfamide linker is required for dHTC1 ternary complex formation
  • CRBN deep mutational scan distinguishes dHTC1 from IMiD ligands
Main Claim 4 –

dHTC1 stabilizes ENL–CRBN via extensive protein-protein interface

Supporting evidence

  • dHTC1 spirosuccinimide binds CRBN tri-Trp IMiD pocket
  • Ternary complex induces CRBN loop and ENL Q41-region shifts
  • Specific ENL–CRBN contacts are required for dHTC1 activity

Abstract

Chemical inducers of proximity (CIPs) stabilize biomolecular interactions, often causing an emergent rewiring of cellular biochemistry. While rational design strategies can expedite the discovery of heterobifunctional CIPs, monovalent, molecular glue-like CIPs have relied predominantly on serendipity. Envisioning a prospective approach to discover molecular glues for a pre-selected target, we hypothesized that pre-existing ligands could be systematically decorated with chemical modifications to empirically discover protein-ligand surfaces that are tuned to cooperatively engage another protein interface. Here, we used sulfur(VI)-fluoride exchange (SuFEx)-based high-throughput chemistry (HTC) to install 3,163 structurally diverse chemical building blocks onto ENL and BRD4 ligands and then screened the crude products for degrader activity. This revealed dHTC1, a potent, selective, and stereochemistry-dependent degrader of ENL. It recruits CRL4CRBN to ENL through an extended interface of protein-protein and protein-ligand contacts, but only after pre-forming the ENL:dHTC1 complex. We also characterized two structurally distinct BRD4 degraders, including dHTC3, a molecular glue that selectively dimerizes the first bromodomain of BRD4 to SCFFBXO, an E3 ligase not previously accessible for chemical rewiring. Altogether, this study introduces HTC as a facile tool to discover new CIPs and actionable cellular effectors of proximity pharmacology.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?